A detailed history of Israel Englander (Millennium Management LLC) transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 41,301 shares of AQST stock, worth $194,527. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,301
Previous 90,862 54.55%
Holding current value
$194,527
Previous $236,000 13.14%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.4 - $5.09 $118,946 - $252,265
-49,561 Reduced 54.55%
41,301 $205,000
Q2 2024

Aug 14, 2024

SELL
$2.31 - $4.5 $932,276 - $1.82 Million
-403,583 Reduced 81.62%
90,862 $236,000
Q1 2024

May 15, 2024

BUY
$2.01 - $6.09 $731,563 - $2.22 Million
363,962 Added 278.93%
494,445 $2.11 Million
Q4 2023

Feb 14, 2024

SELL
$1.29 - $2.47 $248,277 - $475,383
-192,463 Reduced 59.6%
130,483 $263,000
Q2 2023

Aug 14, 2023

BUY
$1.06 - $2.49 $21,303 - $50,044
20,098 Added 6.64%
322,946 $532,000
Q1 2023

May 15, 2023

BUY
$0.72 - $1.15 $184,728 - $295,053
256,568 Added 554.38%
302,848 $345,000
Q4 2022

Feb 14, 2023

SELL
$0.77 - $1.18 $330,785 - $506,917
-429,591 Reduced 90.27%
46,280 $42,000
Q3 2022

Nov 14, 2022

SELL
$0.63 - $1.73 $398,722 - $1.09 Million
-632,893 Reduced 57.08%
475,871 $557,000
Q2 2022

Aug 15, 2022

BUY
$0.64 - $2.57 $543,093 - $2.18 Million
848,584 Added 326.15%
1,108,764 $709,000
Q1 2022

May 16, 2022

SELL
$2.28 - $4.26 $225,024 - $420,440
-98,695 Reduced 27.5%
260,180 $679,000
Q4 2021

Feb 14, 2022

BUY
$3.69 - $6.37 $129,522 - $223,593
35,101 Added 10.84%
358,875 $1.4 Million
Q3 2021

Nov 15, 2021

SELL
$3.25 - $4.66 $370,760 - $531,612
-114,080 Reduced 26.05%
323,774 $1.41 Million
Q2 2021

Aug 16, 2021

BUY
$3.29 - $5.21 $1.44 Million - $2.28 Million
437,854 New
437,854 $1.74 Million
Q1 2021

May 17, 2021

SELL
$4.17 - $6.73 $156,141 - $251,998
-37,444 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$4.65 - $7.79 $174,114 - $291,688
37,444 New
37,444 $200,000
Q3 2020

Nov 16, 2020

SELL
$4.12 - $9.09 $634,673 - $1.4 Million
-154,047 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$1.84 - $6.44 $153,358 - $536,754
-83,347 Reduced 35.11%
154,047 $749,000
Q1 2020

May 14, 2020

SELL
$1.54 - $6.75 $191,917 - $841,198
-124,622 Reduced 34.42%
237,394 $520,000
Q4 2019

Feb 14, 2020

BUY
$3.06 - $8.78 $801,496 - $2.3 Million
261,927 Added 261.69%
362,016 $2.11 Million
Q3 2019

Nov 14, 2019

SELL
$3.04 - $4.91 $504,801 - $815,320
-166,053 Reduced 62.39%
100,089 $318,000
Q2 2019

Aug 14, 2019

BUY
$3.72 - $6.95 $990,048 - $1.85 Million
266,142 New
266,142 $1.12 Million
Q1 2019

May 14, 2019

SELL
$5.74 - $8.05 $132,077 - $185,230
-23,010 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$6.09 - $18.0 $140,130 - $414,180
23,010 New
23,010 $145,000

Others Institutions Holding AQST

About Aquestive Therapeutics, Inc.


  • Ticker AQST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,350,700
  • Market Cap $251M
  • Description
  • Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...
More about AQST
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.